SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Aktis Oncology Q3 2026 net loss widens 93% to $29.9 million

Aktis Oncology Q3 2026 net loss widens 93% to $29.9 million Aktis Oncology’s third-quarter 2026

AKTS

Related stories